Drug Discovery and Development: Technology in Transition

— —

Raymond G Hill (President, British Pharmacological Society, London, UK) Duncan Richards (Professor Duncan Richards MA DM FRCP FFPM FBPharmacolS, St Hilda's College,Oxford)

Drug Discovery and Development

Technology in Transition

Raymond G Hill (President, British Pharmacological Society, London, UK), Duncan Richards (Professor Duncan Richards MA DM FRCP FFPM FBPharmacolS, St Hilda's College,Oxford)

$110.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Elsevier Health Sciences
24 August 2021

Medicine: general issues; Pharmacology; Pharmacy & dispensing

Essential insight into drug development and the pharmaceutical industry

With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the new edition of Drug Discovery and Development is an essential resource for anyone interested in understanding how drugs and other therapeutic interventions are discovered and developed, through to clinical research, registration, and market access.

The text has been thoroughly updated, with new information on biopharmaceuticals and vaccines as well as clinical development and target identification. Drug discovery and development continues to evolve rapidly and this new edition reflects important changes in the landscape.

Edited by industry experts Raymond Hill and Duncan Richards, this market-leading text is suitable for undergraduates and graduates undertaking degrees in pharmacy, pharmacology, toxicology, and clinical development through to those embarking on a career in the pharmaceutical industry.

Key stages of drug discovery and development

Chapters outline the contribution of individual disciplines to the overall process

Supplemented by specific chapters on different modalities

Includes coverage of Oligonucleotide therapies; cell and gene therapy

Now comes with online access on StudentConsult

Edited by: Raymond G Hill (President British Pharmacological Society London UK), Duncan Richards (Professor Duncan Richards MA DM FRCP FFPM FBPharmacolS, St Hilda's College, Oxford)
Imprint: Elsevier Health Sciences
Country of Publication: United Kingdom
Edition: 3rd edition
Dimensions: Height: 235mm, Width: 191mm,
Weight: 810g
ISBN: 9780702078040
ISBN 10: 0702078042
Pages: 384
Publication Date: 24 August 2021
Audience: College/higher education , Primary
Replaced By: 9780702042997
Format: Paperback
Publisher's Status: Active

Section 1 Introduction and Background 1. Development of the pharmaceutical industry 2. Nature of disease and purpose of therapy 3. Therapeutic modalities Section 2 Drug Discovery 4. Drug target identification 5. Selecting the modality and planning the project 6. High throughput screening 7. Medicinal Chemistry 8. Biopharmaceuticals and related molecules 9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process 10. Metabolism and Pharmacokinetical strategies. 11. Role of pharmacology to include pharmacology of newer modalities 12. In vitro in vivo translation 13. Vaccines Section 3 Drug Development 14. Drug development introduction 15. Drug safety 16. Pharmaceutical development 17. Clinical development 18. Clinical imaging 19. Intellectual property 20. Regulatory affairs 21. Marketing and Patient access to medicines Section 4 Facts and Figures 22. Facts and Figures; and the Future